Metraipolis › archive › dc_7e3fa7a74ea6

Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42432797
DOI
10.1186/s13046-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-18T09:01:12.425Z
SHA-256 of the archived text
e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7
Stable URL of this page
https://metraipolis.com/documento/dc_7e3fa7a74ea6

How to cite

Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797 — Europe PMC (en), https://europepmc.org/article/MED/42432797 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e3fa7a74ea6 (Metraipolis archive dc_7e3fa7a74ea6, sha256 e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7)
BibTeX
@misc{dc7e3fa7a74ea6,
  title = {Suppression of the myofibroblastic cancer-associated fibroblast phenotype to enhance anti-PD-1 response — Europe PMC PMID:42432797},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42432797},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e3fa7a74ea6; sha256 e83fe5c912e28ab759552b55e8901857fa2131c384061ef622d3b82fda0e3ea7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42432797. Agents can read the archived copy with the MCP tool read_document.